stoxline Quote Chart Rank Option Currency Glossary
  
Mainz Biomed B.V. (MYNZ)
0.2334  0.013 (6.09%)    11-08 16:00
Open: 0.223
High: 0.2498
Volume: 2,659,409
  
Pre. Close: 0.22
Low: 0.216
Market Cap: 5(M)
Technical analysis
2024-11-08 4:47:59 PM
Short term     
Mid term     
Targets 6-month :  0.38 1-year :  0.46
Resists First :  0.32 Second :  0.4
Pivot price 0.25
Supports First :  0.21 Second :  0.17
MAs MA(5) :  0.23 MA(20) :  0.26
MA(100) :  0.33 MA(250) :  0.71
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  12 D(3) :  13.9
RSI RSI(14): 42.3
52-week High :  1.78 Low :  0.18
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ MYNZ ] has closed above bottom band by 29.1%. Bollinger Bands are 45.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 12 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.25 - 0.25 0.25 - 0.25
Low: 0.21 - 0.21 0.21 - 0.22
Close: 0.23 - 0.23 0.23 - 0.23
Company Description

Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.

Headline News

Mon, 21 Oct 2024
Mainz Biomed Highlights Growth and Innovations for 2025 - TipRanks

Fri, 18 Oct 2024
Mainz Biomed Sees Revenue Growth Amid Cost Reductions - TipRanks

Thu, 10 Oct 2024
Mainz Biomed Secures Additional $1.5M Funding - Yahoo Finance

Thu, 03 Oct 2024
Mainz Biomed Executes Convertible Note Agreement - TipRanks

Mon, 23 Sep 2024
Mainz Biomed stock plunges to 52-week low of $0.21 - Investing.com

Thu, 12 Sep 2024
Mainz Biomed stock plunges to 52-week low of $0.3 amid market challenges - Investing.com

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Shares Out -13 (M)
Shares Float 0 (M)
Held by Insiders 2.559e+007 (%)
Held by Institutions 2.209e+007 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS 0
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -1.12
Profit Margin 0 %
Operating Margin -1 %
Return on Assets (ttm) 883.2 %
Return on Equity (ttm) -99.3 %
Qtrly Rev. Growth 333.7 %
Gross Profit (p.s.) 123.33
Sales Per Share -3368.89
EBITDA (p.s.) 0
Qtrly Earnings Growth -2.159e+007 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0
Price to Book value -0.22
Price to Sales -0.01
Price to Cash Flow 0
Stock Dividends
Dividend 1.7e+006
Forward Dividend 720640
Dividend Yield 728363000%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android